Home > Browse Issues > Vol.48 No.11

miR-9-5p Targets and Inhibits IGF2 to Activate Microglia and Promote Neuroinflammatory Responses in a Tic Disorder Mode


lYUAN Xianying*, WANG Xiangxiang, LI Jie, SONG Yayu, ZHANG Lin, JIA Jiaojiao

(Handan Maternity and Child Health Hospital, Handan 056001, China)
Abstract:

This study was to investigating the mechanism of action of miR-9-5p on neuroinflammation in rats with tic disorder models. A tic disorder model was established in 82 SD rats via intraperitoneal injection of an IDPN (iminodipropionitrile) solution. The successfully modelled rats were randomly allocated to the Model group, Inhibitor negative control group (Inhibitor NC group), miR-9-5p inhibitor group, and miR-9-5p inhibitor+IGF2 (insulin-like growth factor 2) inhibitor group (miR-9-5p inhibitor+si-IGF2 group), with 18 rats in each group. Ad ditionally, 18 healthy rats were designated as the control group (Control group). Verification of the miR-9-5p-IGF2 targeting relationship using Starbase tools and dual luciferase assays. RT-qPCR was employed to detect miR-9-5p and IGF2 mRNA expression levels in rat striatal tissue; Western blot analysis was conducted to assess IGF2 protein expression levels in rat striatal tissue; behavioural testing was performed on rats; HE (haematoxylin and eosin) and Nissl staining were used to observe pathological alterations and neuronal morphological changes in rat striatal tis sue respectively; ELISA was employed to measure TNF-α (tumour necrosis factor-α), IL-6 (interleukin-6), IL-10 and  TGF-β (transforming growth factor-β) levels in rat striatal tissue. Immunofluorescence co-staining was used to detect expression of the microglial marker proteins Iba-1 (ionized calcium-binding adapter molecule 1), CD86, and CD206 in rat striatal tissue. Western blot analysis of p-PI3K (phosphorylated phosphoinositide 3-kinase) and p-AKT (phosphorylated protein kinase B) protein expression levels in rat striatal tissue. The results show that compared with the Control group, rats in the Model group exhibited significantly elevated levels of miR-9-5p alongside mark edly increased motor behaviour scores and stereotypy scores (P<0.05). IGF2 mRNA and protein expression levels were markedly reduced (P<0.05), while striatal histopathological damage worsened, characterised by sparse Nissl bodies and a significant reduction in neuronal cell numbers (P<0.05). Levels of TNF-α, IL-6, Iba-1, and CD86 were markedly elevated (P<0.05), while levels of IL-10, TGF-β, and CD206, along with p-PI3K/PI3K and p-AKT/AKT values, were significantly reduced (P<0.05). Compared with the Model group, rats in the miR-9-5p inhibitor group exhibited significantly reduced levels of miR-9-5p, motor behaviour scores, and stereotypy scores (P<0.05). IGF2 mRNA and protein expression levels were markedly elevated (P<0.05), with reduced pathological damage in striatal tissue and a significant increase in neuronal cell numbers (P<0.05). Levels of TNF-α, IL-6, Iba-1, and CD86 were markedly reduced (P<0.05), while levels of IL-10, TGF-β, and CD206, along with p-PI3K/PI3K and p-AKT/AKT values, were significantly elevated (P<0.05). Downregulation of IGF2 partially reversed the inhibitory effects of miR-9-5p inhibitors on behavioural scores, striatal histopathological damage, microglial activation, and neuroinflammation in model rats. In summary, inhibition of miR-9-5p may suppress M1-type glial cell polarisation and promote M2-type polarisation by targeting IGF2 regulation and activating the PI3K/AKT signalling pathway, thereby alleviating neu roinflammation and improving tic disorders in rats.


CSTR: 32200.14.cjcb.2026.11.0007